Corstasis Therapeutics is a biopharmaceutical company involved in the development and commercialization of prescription medicines. Its work centers on small‑molecule therapeutics and optimized drug‑delivery approaches designed to enable reliable systemic dosing and improve treatment accessibility in outpatient settings.
The company oversees clinical development, regulatory submissions, and manufacturing partnerships to advance its products to market. Corstasis operates at the intersection of pharmaceuticals and drug‑delivery technology, aiming to translate established science into practical, patient‑ready therapies.